FirstWord HealthTech’s Post

🔬 Breaking new ground in drug development! The world’s first drug candidate developed using organoid technology and AI has dosed its first patient in a Phase 1 clinical study. The therapy targets diffusive gastric cancer, a condition with unmet therapeutic needs. This innovative approach combines cutting-edge AI capabilities with patient-derived organoids, accelerating the identification of highly targeted and personalized therapies. It's exciting to see how technology is reshaping the future of drug discovery. Kudos to the teams pioneering this groundbreaking work. Together, we’re making strides toward a healthier future. 💡 #DrugDevelopment #AI #OrganoidTechnology #Oncology #InnovativeTherapies #RareMoon

Cell cycle analysis is crucial for investigating cancer therapeutics, especially to understand population heterogeneity and identify outliers with drug resistance. Livecyte combines label-free Quantitative Phase Imaging (QPI) with fluorescence to provide deep insights into cell-cycle changes. Analyse both at the population and single-cell levels to assess dry mass, growth, and time spent in each phase of the cycle. 🧬 Check out the video to see this in action 👇 #CancerResearch #CellBiology #Microscopy #DrugDiscovery #LifeSciences

📢 News: Sonrai Accelerates Cancer Therapeutics Research with Advanced Analytics 📰 Read now: https://lnkd.in/dPMqy8D2 Sonrai’s AI data management and analysis technology will enable the Henri & Belinda Termeer Center for Targeted Therapies at Massachusetts General Hospital to manage vast multi-omic and multi-modal data to accelerate oncological research into personalized therapies using advanced analytics. 👋 To discuss how we can help advance your therapeutics development, book a chat with us: https://lnkd.in/dEnkdQdV #precisionmedicine #oncology #AI #dataanalytics #Sonrai #SonraiDiscovery #drugdevelopment #immunooncology #biomarkerdiscovery

🔬 Join Crown Bioscience for an upcoming webinar to explore how Antibody-drug conjugates (ADCs) are revolutionizing cancer treatment with improved targeting, reduced toxicity, and enhanced efficacy. 💡 Learn about cutting-edge advancements in bioconjugation technology and multi-omics approaches driving ADCs from preclinical to clinical stages. 🔍 Dr. Peng Wang, PhD, will share strategies for optimizing ADCs, overcoming resistance, and combining them with immuno-oncology therapies. ➡️ REGISTER HERE: https://buff.ly/3A9LOzt #DrugDevelopment #PrecisionMedicine #DrugDiscovery #ClinicalResearch #Oncology #OncologyDrugs #TherapeuticAreas #AntibodyDrugConjugate #PreClinical #BasicResearch

🔈 📣 interested to learn about strategies for optimizing ADCs, overcoming resistance, and combining them with immuno-oncology therapies? 👉 Check out this webinar below! #ADC #cancertreatment #crownbioscience 🔬

An important new white paper, released today, highlights Predictive Oncology’s success in using artificial intelligence-powered evidence-based molecular decision-making for improved outcomes in ovarian cancer. This white paper details a multi-year collaboration between Predictive Oncology and UPMC Magee-Womens Hospital applying data-driven artificial intelligence machine learning (ML) to predict survival outcomes for ovarian high grade serous carcinoma patients (HGSC). Visit https://lnkd.in/gwzK8xZJ to download the study. #drugdiscovery #drugdevelopment #pharma #emergingtechnologies #biopharma #biomarker #biomarkerdiscovery #molecularbiology #oncologydrugdiscovery  #oncology #machinelearning #AI #marketaccess #artificialintelligence #digitaltransformation #cancerresearch #biotech  #lifesciences #POAI

Exosomes, nanosized vesicles released from cells, are gaining popularity as drug delivery vehicles due to their ability to escape liver homing and undesired accumulation. Bovine milk/colostrum-derived exosomes, functionalized for cancer therapeutics, show promise, including validation of anti-tumor efficacy. Check out this free webinar by our friends at Spectral Instruments Imaging on June 11, at 10 AM PDT (12 PM CDT / 1 PM EDT), and learn how milk exosomes can be utilized for targeted drug delivery & the latest advancements in RNA & DNA delivery using the Exosome-PEI-Matrix (EPM) technology: https://lnkd.in/drnTd6kW #Oncology #Exosomes #Milk #Imaging #PreclinicalImaging

The Lipidomics Forum opened yesterday. Visit us at our booth, come by, enjoy networking and learn more about unique fragmentation technology #OAD that can help you explore the structure of lipids in more detail! 👉 https://lnkd.in/dkH8ZCpV #lipidomics #metabolomics #lipids #oncology

Exploring extracellular vesicles as a drug delivery system for cancer therapy: in this review article, Jiabing Lian at China Medical University and collaborators offered a comprehensive overview of extracellular vesicles, detailing their biogenesis and absorption mechanisms. Additionally, they explored current research efforts aimed at utilizing EVs as drug carriers, covering purification techniques, drug loading, and bioengineering for targeted delivery https://lnkd.in/eTCm_t4Z Their analysis highlighted the potential of EVs as versatile and effective tools for drug delivery, especially in cancer therapy. An article co-authored by Jin Wang and Bohang Yin #extracellularvesicles #exosomes #drugdelivery #cancertherapy #bioengineering #Vesiculab

CTC diagnostics involves the detection and analysis of cancer cells that have broken away from the primary tumor and are circulating in the bloodstream. These cells provide invaluable insights into the progression of cancer, enabling oncologists to monitor the disease in real-time, tailor treatments to individual patients, and potentially improve outcomes.   Top Global Circulating Tumor Cell Diagnostics Industry Players: QIAGEN Bio-Techne Precision For Medicine BioCep Greiner Bio-One International Ikonisys Miltenyi Biotec BioFluidica, Inc. Biolidics Limited (Formerly known as Clearbridge BioMedics) Epic Sciences Rarecells ScreenCell Menarini Silicon Biosystems Vitatex Inc   Read More @ https://lnkd.in/dz9zMhuj   #ctcdiagnostics #liquidbiopsy #precisionmedicine #cancerdiagnostics #oncology #biotechnology #medtech #ctc #marketgrowth#liquidbiopsy #personalizedmedicinerevolution #healthcare #investinginhealthcare #ctcdrugdevelopment #earlycancerdetection #residualdisease #cancertreatment #startup #metastatinsight